We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
TARIS Biomedical, a company developing targeted new therapies for millions of patients suffering from difficult-to-treat bladder diseases, announced today that it has raised $25M in a Series B financing